Correlation between anti-Müllerian hormone, hypertension and vascular age: the Generation R Study, a population-based prospective cohort study

R. H.M. Dykgraaf; S. Schalekamp-Timmermans; S. A.A. van den Berg; E. J. Vinke; E. A.P. Steegers; J. S.E. Laven; Y. V. Louwers

doi:10.1016/j.maturitas.2025.108785

Correlation between anti-Müllerian hormone, hypertension and vascular age: the Generation R Study, a population-based prospective cohort study

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

3 Downloads (Pure)

Abstract

Objective:

The objective of this study was to explore the relationship between levels of anti-Müllerian hormone (AMH) and the risk of hypertension and vascular ageing in a population-based cohort.

Study design:

This study was embedded in the Generation R Study, a prospective population-based cohort study of children and their parents in the City of Rotterdam, the Netherlands. The present study included all women at the first recall visit with available data on AMH and blood pressure (n = 4883) and analysed the association between AMH and hypertension. AMH levels (first recall visit) and carotid artery intima-medial thickness (CIMT) measurements (second recall visit) were used to analyse the association between AMH serum levels and CIMT as a proxy for vascular age (n = 3508).

Results:

A higher age and lower AMH percentiles (adjusted for age) were associated with an increased risk of hypertension. Women with AMH percentiles <p10 had a 2.1 times higher risk of hypertension than women with AMH levels >p90 (P < .001). Vascular age, conducted from CIMT measurements (second recall visit), was on average 9.8 years older than chronological age in those with an AMH below p10 (first recall visit). This difference was 6.1 years in those with an AMH exceeding p90. Similarly, differences in medians between the groups were significant (p < 0,008).

Conclusions:

This large prospective cohort study shows that low AMH levels later in life, independent of age, are associated with hypertension. The results indicate that diminished ovarian reserve at a younger age is associated with indicators of vascular alterations. Women with low AMH levels should not only be counseled about potential fertility issues, but should also be informed about their increased risk of vascular damage in order to take appropriate preventive measures. In the future, AMH may serve as a prospective marker for the early detection of cardiovascular diseases.

Original language	English
Article number	108785
Journal	Maturitas
Volume	204
DOIs	https://doi.org/10.1016/j.maturitas.2025.108785
Publication status	Published - Jan 2026

Bibliographical note

Publisher Copyright:
© 2025 The Authors

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.maturitas.2025.108785Licence: CC BY

Correlation between anti-Müllerian hormone, hypertension and vascular ageFinal published version, 708 KBLicence: CC BY

Cite this

Dykgraaf, R. H. M., Schalekamp-Timmermans, S., van den Berg, S. A. A., Vinke, E. J., Steegers, E. A. P., Laven, J. S. E., & Louwers, Y. V. (2026). Correlation between anti-Müllerian hormone, hypertension and vascular age: the Generation R Study, a population-based prospective cohort study. Maturitas, 204, Article 108785. https://doi.org/10.1016/j.maturitas.2025.108785

@article{3d0febafbb5547798636c8567db0e8ea,

title = "Correlation between anti-M{\"u}llerian hormone, hypertension and vascular age: the Generation R Study, a population-based prospective cohort study",

abstract = "Objective: The objective of this study was to explore the relationship between levels of anti-M{\"u}llerian hormone (AMH) and the risk of hypertension and vascular ageing in a population-based cohort.Study design: This study was embedded in the Generation R Study, a prospective population-based cohort study of children and their parents in the City of Rotterdam, the Netherlands. The present study included all women at the first recall visit with available data on AMH and blood pressure (n = 4883) and analysed the association between AMH and hypertension. AMH levels (first recall visit) and carotid artery intima-medial thickness (CIMT) measurements (second recall visit) were used to analyse the association between AMH serum levels and CIMT as a proxy for vascular age (n = 3508). Results: A higher age and lower AMH percentiles (adjusted for age) were associated with an increased risk of hypertension. Women with AMH percentiles p90 (P < .001). Vascular age, conducted from CIMT measurements (second recall visit), was on average 9.8 years older than chronological age in those with an AMH below p10 (first recall visit). This difference was 6.1 years in those with an AMH exceeding p90. Similarly, differences in medians between the groups were significant (p < 0,008). Conclusions: This large prospective cohort study shows that low AMH levels later in life, independent of age, are associated with hypertension. The results indicate that diminished ovarian reserve at a younger age is associated with indicators of vascular alterations. Women with low AMH levels should not only be counseled about potential fertility issues, but should also be informed about their increased risk of vascular damage in order to take appropriate preventive measures. In the future, AMH may serve as a prospective marker for the early detection of cardiovascular diseases.",

author = "Dykgraaf, \{R. H.M.\} and S. Schalekamp-Timmermans and \{van den Berg\}, \{S. A.A.\} and Vinke, \{E. J.\} and Steegers, \{E. A.P.\} and Laven, \{J. S.E.\} and Louwers, \{Y. V.\}",

note = "Publisher Copyright: {\textcopyright} 2025 The Authors",

year = "2026",

month = jan,

doi = "10.1016/j.maturitas.2025.108785",

language = "English",

volume = "204",

journal = "Maturitas",

issn = "0378-5122",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Correlation between anti-Müllerian hormone, hypertension and vascular age

T2 - the Generation R Study, a population-based prospective cohort study

AU - Dykgraaf, R. H.M.

AU - Schalekamp-Timmermans, S.

AU - van den Berg, S. A.A.

AU - Vinke, E. J.

AU - Steegers, E. A.P.

AU - Laven, J. S.E.

AU - Louwers, Y. V.

PY - 2026/1

Y1 - 2026/1

N2 - Objective: The objective of this study was to explore the relationship between levels of anti-Müllerian hormone (AMH) and the risk of hypertension and vascular ageing in a population-based cohort.Study design: This study was embedded in the Generation R Study, a prospective population-based cohort study of children and their parents in the City of Rotterdam, the Netherlands. The present study included all women at the first recall visit with available data on AMH and blood pressure (n = 4883) and analysed the association between AMH and hypertension. AMH levels (first recall visit) and carotid artery intima-medial thickness (CIMT) measurements (second recall visit) were used to analyse the association between AMH serum levels and CIMT as a proxy for vascular age (n = 3508). Results: A higher age and lower AMH percentiles (adjusted for age) were associated with an increased risk of hypertension. Women with AMH percentiles p90 (P < .001). Vascular age, conducted from CIMT measurements (second recall visit), was on average 9.8 years older than chronological age in those with an AMH below p10 (first recall visit). This difference was 6.1 years in those with an AMH exceeding p90. Similarly, differences in medians between the groups were significant (p < 0,008). Conclusions: This large prospective cohort study shows that low AMH levels later in life, independent of age, are associated with hypertension. The results indicate that diminished ovarian reserve at a younger age is associated with indicators of vascular alterations. Women with low AMH levels should not only be counseled about potential fertility issues, but should also be informed about their increased risk of vascular damage in order to take appropriate preventive measures. In the future, AMH may serve as a prospective marker for the early detection of cardiovascular diseases.

AB - Objective: The objective of this study was to explore the relationship between levels of anti-Müllerian hormone (AMH) and the risk of hypertension and vascular ageing in a population-based cohort.Study design: This study was embedded in the Generation R Study, a prospective population-based cohort study of children and their parents in the City of Rotterdam, the Netherlands. The present study included all women at the first recall visit with available data on AMH and blood pressure (n = 4883) and analysed the association between AMH and hypertension. AMH levels (first recall visit) and carotid artery intima-medial thickness (CIMT) measurements (second recall visit) were used to analyse the association between AMH serum levels and CIMT as a proxy for vascular age (n = 3508). Results: A higher age and lower AMH percentiles (adjusted for age) were associated with an increased risk of hypertension. Women with AMH percentiles p90 (P < .001). Vascular age, conducted from CIMT measurements (second recall visit), was on average 9.8 years older than chronological age in those with an AMH below p10 (first recall visit). This difference was 6.1 years in those with an AMH exceeding p90. Similarly, differences in medians between the groups were significant (p < 0,008). Conclusions: This large prospective cohort study shows that low AMH levels later in life, independent of age, are associated with hypertension. The results indicate that diminished ovarian reserve at a younger age is associated with indicators of vascular alterations. Women with low AMH levels should not only be counseled about potential fertility issues, but should also be informed about their increased risk of vascular damage in order to take appropriate preventive measures. In the future, AMH may serve as a prospective marker for the early detection of cardiovascular diseases.

UR - https://www.scopus.com/pages/publications/105022887166

U2 - 10.1016/j.maturitas.2025.108785

DO - 10.1016/j.maturitas.2025.108785

M3 - Article

C2 - 41314127

AN - SCOPUS:105022887166

SN - 0378-5122

VL - 204

JO - Maturitas

JF - Maturitas

M1 - 108785

ER -

Correlation between anti-Müllerian hormone, hypertension and vascular age: the Generation R Study, a population-based prospective cohort study

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this